Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome
Gespeichert in:
| Veröffentlicht in: | Leukemia 2021-12, Vol.35 (12), p.3622-3624 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3624 |
|---|---|
| container_issue | 12 |
| container_start_page | 3622 |
| container_title | Leukemia |
| container_volume | 35 |
| creator | Taga, Takashi Tanaka, Shiro Hasegawa, Daisuke Terui, Kiminori Toki, Tsutomu Iwamoto, Shotaro Hiramatsu, Hidefumi Miyamura, Takako Hashii, Yoshiko Moritake, Hiroshi Nakayama, Hideki Takahashi, Hiroyuki Shimada, Akira Taki, Tomohiko Ito, Etsuro Hama, Asahito Ito, Masafumi Koh, Katsuyoshi Hasegawa, Daiichiro Saito, Akiko M. Adachi, Souichi Tomizawa, Daisuke |
| description | |
| doi_str_mv | 10.1038/s41375-021-01397-w |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2568597913</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A684321652</galeid><sourcerecordid>A684321652</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-e4028d249b495ec4646eec157a94649ca85e98649b8a30872d4ef169d8ea1c723</originalsourceid><addsrcrecordid>eNp9kl1rFDEUhgdRcK3-Aa8CgniTNpl8TOLdsrW10GIp9TpkM2e2qTNJTWZY9sq_bsYRakUkFzmcPO85J8lbVW8pOaaEqZPMKWsEJjXFhDLd4P2zakV5I7EQgj6vVkSpBktd85fVq5zvCZkP5ar6sYkpgRt9DGiMH9F1zCP2oZ2W1NXNKdoe0NnmCtnQovP17Zri680NsglQ9rvgO-9sGNFDirtQtN6hzroxpoy6mNBwgD76FvUwfYPBWxQ7dBr3AeVDaFMc4HX1orN9hje_96Pq69mn281nfPnl_GKzvsROMD5i4KRWbc31lmsBjksuARwVjdUl1s4qAVqVaKssI6qpWw4dlbpVYKlranZUfVjqlkG_T5BHM_jsoO9tgDhlUwuphG40ZQV99xd6H6cUynSmloRLITkjj9TO9mB86OKYrJuLmrVUnNVUirnt8T-ostryGi4G6HzJPxG8_0NwB7Yf73Lsp_k38lOwXkCXYs4JOvOQ_GDTwVBiZk-YxROmeML88oTZFxFbRLnAYQfp8Wr_Uf0EDJS27A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604656430</pqid></control><display><type>article</type><title>Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome</title><source>Alma/SFX Local Collection</source><creator>Taga, Takashi ; Tanaka, Shiro ; Hasegawa, Daisuke ; Terui, Kiminori ; Toki, Tsutomu ; Iwamoto, Shotaro ; Hiramatsu, Hidefumi ; Miyamura, Takako ; Hashii, Yoshiko ; Moritake, Hiroshi ; Nakayama, Hideki ; Takahashi, Hiroyuki ; Shimada, Akira ; Taki, Tomohiko ; Ito, Etsuro ; Hama, Asahito ; Ito, Masafumi ; Koh, Katsuyoshi ; Hasegawa, Daiichiro ; Saito, Akiko M. ; Adachi, Souichi ; Tomizawa, Daisuke</creator><creatorcontrib>Taga, Takashi ; Tanaka, Shiro ; Hasegawa, Daisuke ; Terui, Kiminori ; Toki, Tsutomu ; Iwamoto, Shotaro ; Hiramatsu, Hidefumi ; Miyamura, Takako ; Hashii, Yoshiko ; Moritake, Hiroshi ; Nakayama, Hideki ; Takahashi, Hiroyuki ; Shimada, Akira ; Taki, Tomohiko ; Ito, Etsuro ; Hama, Asahito ; Ito, Masafumi ; Koh, Katsuyoshi ; Hasegawa, Daiichiro ; Saito, Akiko M. ; Adachi, Souichi ; Tomizawa, Daisuke</creatorcontrib><identifier>ISSN: 0887-6924</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/s41375-021-01397-w</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/1059/99 ; 692/499 ; Cancer Research ; Correction ; Critical Care Medicine ; Hematology ; Intensive ; Internal Medicine ; Medicine ; Medicine & Public Health ; Oncology</subject><ispartof>Leukemia, 2021-12, Vol.35 (12), p.3622-3624</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2021</rights><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-e4028d249b495ec4646eec157a94649ca85e98649b8a30872d4ef169d8ea1c723</citedby><orcidid>0000-0001-5471-7646 ; 0000-0002-9446-9568 ; 0000-0002-0168-2475 ; 0000-0002-1994-113X ; 0000-0003-1520-7007 ; 0000-0002-0061-9781 ; 0000-0001-8763-0280 ; 0000-0003-3136-5670 ; 0000-0002-3226-556X ; 0000-0002-7710-2449 ; 0000-0003-0525-4766 ; 0000-0002-7582-0201 ; 0000-0002-0476-4978</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Taga, Takashi</creatorcontrib><creatorcontrib>Tanaka, Shiro</creatorcontrib><creatorcontrib>Hasegawa, Daisuke</creatorcontrib><creatorcontrib>Terui, Kiminori</creatorcontrib><creatorcontrib>Toki, Tsutomu</creatorcontrib><creatorcontrib>Iwamoto, Shotaro</creatorcontrib><creatorcontrib>Hiramatsu, Hidefumi</creatorcontrib><creatorcontrib>Miyamura, Takako</creatorcontrib><creatorcontrib>Hashii, Yoshiko</creatorcontrib><creatorcontrib>Moritake, Hiroshi</creatorcontrib><creatorcontrib>Nakayama, Hideki</creatorcontrib><creatorcontrib>Takahashi, Hiroyuki</creatorcontrib><creatorcontrib>Shimada, Akira</creatorcontrib><creatorcontrib>Taki, Tomohiko</creatorcontrib><creatorcontrib>Ito, Etsuro</creatorcontrib><creatorcontrib>Hama, Asahito</creatorcontrib><creatorcontrib>Ito, Masafumi</creatorcontrib><creatorcontrib>Koh, Katsuyoshi</creatorcontrib><creatorcontrib>Hasegawa, Daiichiro</creatorcontrib><creatorcontrib>Saito, Akiko M.</creatorcontrib><creatorcontrib>Adachi, Souichi</creatorcontrib><creatorcontrib>Tomizawa, Daisuke</creatorcontrib><title>Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome</title><title>Leukemia</title><addtitle>Leukemia</addtitle><subject>631/67/1059/99</subject><subject>692/499</subject><subject>Cancer Research</subject><subject>Correction</subject><subject>Critical Care Medicine</subject><subject>Hematology</subject><subject>Intensive</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><issn>0887-6924</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kl1rFDEUhgdRcK3-Aa8CgniTNpl8TOLdsrW10GIp9TpkM2e2qTNJTWZY9sq_bsYRakUkFzmcPO85J8lbVW8pOaaEqZPMKWsEJjXFhDLd4P2zakV5I7EQgj6vVkSpBktd85fVq5zvCZkP5ar6sYkpgRt9DGiMH9F1zCP2oZ2W1NXNKdoe0NnmCtnQovP17Zri680NsglQ9rvgO-9sGNFDirtQtN6hzroxpoy6mNBwgD76FvUwfYPBWxQ7dBr3AeVDaFMc4HX1orN9hje_96Pq69mn281nfPnl_GKzvsROMD5i4KRWbc31lmsBjksuARwVjdUl1s4qAVqVaKssI6qpWw4dlbpVYKlranZUfVjqlkG_T5BHM_jsoO9tgDhlUwuphG40ZQV99xd6H6cUynSmloRLITkjj9TO9mB86OKYrJuLmrVUnNVUirnt8T-ostryGi4G6HzJPxG8_0NwB7Yf73Lsp_k38lOwXkCXYs4JOvOQ_GDTwVBiZk-YxROmeML88oTZFxFbRLnAYQfp8Wr_Uf0EDJS27A</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Taga, Takashi</creator><creator>Tanaka, Shiro</creator><creator>Hasegawa, Daisuke</creator><creator>Terui, Kiminori</creator><creator>Toki, Tsutomu</creator><creator>Iwamoto, Shotaro</creator><creator>Hiramatsu, Hidefumi</creator><creator>Miyamura, Takako</creator><creator>Hashii, Yoshiko</creator><creator>Moritake, Hiroshi</creator><creator>Nakayama, Hideki</creator><creator>Takahashi, Hiroyuki</creator><creator>Shimada, Akira</creator><creator>Taki, Tomohiko</creator><creator>Ito, Etsuro</creator><creator>Hama, Asahito</creator><creator>Ito, Masafumi</creator><creator>Koh, Katsuyoshi</creator><creator>Hasegawa, Daiichiro</creator><creator>Saito, Akiko M.</creator><creator>Adachi, Souichi</creator><creator>Tomizawa, Daisuke</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5471-7646</orcidid><orcidid>https://orcid.org/0000-0002-9446-9568</orcidid><orcidid>https://orcid.org/0000-0002-0168-2475</orcidid><orcidid>https://orcid.org/0000-0002-1994-113X</orcidid><orcidid>https://orcid.org/0000-0003-1520-7007</orcidid><orcidid>https://orcid.org/0000-0002-0061-9781</orcidid><orcidid>https://orcid.org/0000-0001-8763-0280</orcidid><orcidid>https://orcid.org/0000-0003-3136-5670</orcidid><orcidid>https://orcid.org/0000-0002-3226-556X</orcidid><orcidid>https://orcid.org/0000-0002-7710-2449</orcidid><orcidid>https://orcid.org/0000-0003-0525-4766</orcidid><orcidid>https://orcid.org/0000-0002-7582-0201</orcidid><orcidid>https://orcid.org/0000-0002-0476-4978</orcidid></search><sort><creationdate>20211201</creationdate><title>Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome</title><author>Taga, Takashi ; Tanaka, Shiro ; Hasegawa, Daisuke ; Terui, Kiminori ; Toki, Tsutomu ; Iwamoto, Shotaro ; Hiramatsu, Hidefumi ; Miyamura, Takako ; Hashii, Yoshiko ; Moritake, Hiroshi ; Nakayama, Hideki ; Takahashi, Hiroyuki ; Shimada, Akira ; Taki, Tomohiko ; Ito, Etsuro ; Hama, Asahito ; Ito, Masafumi ; Koh, Katsuyoshi ; Hasegawa, Daiichiro ; Saito, Akiko M. ; Adachi, Souichi ; Tomizawa, Daisuke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-e4028d249b495ec4646eec157a94649ca85e98649b8a30872d4ef169d8ea1c723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>631/67/1059/99</topic><topic>692/499</topic><topic>Cancer Research</topic><topic>Correction</topic><topic>Critical Care Medicine</topic><topic>Hematology</topic><topic>Intensive</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taga, Takashi</creatorcontrib><creatorcontrib>Tanaka, Shiro</creatorcontrib><creatorcontrib>Hasegawa, Daisuke</creatorcontrib><creatorcontrib>Terui, Kiminori</creatorcontrib><creatorcontrib>Toki, Tsutomu</creatorcontrib><creatorcontrib>Iwamoto, Shotaro</creatorcontrib><creatorcontrib>Hiramatsu, Hidefumi</creatorcontrib><creatorcontrib>Miyamura, Takako</creatorcontrib><creatorcontrib>Hashii, Yoshiko</creatorcontrib><creatorcontrib>Moritake, Hiroshi</creatorcontrib><creatorcontrib>Nakayama, Hideki</creatorcontrib><creatorcontrib>Takahashi, Hiroyuki</creatorcontrib><creatorcontrib>Shimada, Akira</creatorcontrib><creatorcontrib>Taki, Tomohiko</creatorcontrib><creatorcontrib>Ito, Etsuro</creatorcontrib><creatorcontrib>Hama, Asahito</creatorcontrib><creatorcontrib>Ito, Masafumi</creatorcontrib><creatorcontrib>Koh, Katsuyoshi</creatorcontrib><creatorcontrib>Hasegawa, Daiichiro</creatorcontrib><creatorcontrib>Saito, Akiko M.</creatorcontrib><creatorcontrib>Adachi, Souichi</creatorcontrib><creatorcontrib>Tomizawa, Daisuke</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taga, Takashi</au><au>Tanaka, Shiro</au><au>Hasegawa, Daisuke</au><au>Terui, Kiminori</au><au>Toki, Tsutomu</au><au>Iwamoto, Shotaro</au><au>Hiramatsu, Hidefumi</au><au>Miyamura, Takako</au><au>Hashii, Yoshiko</au><au>Moritake, Hiroshi</au><au>Nakayama, Hideki</au><au>Takahashi, Hiroyuki</au><au>Shimada, Akira</au><au>Taki, Tomohiko</au><au>Ito, Etsuro</au><au>Hama, Asahito</au><au>Ito, Masafumi</au><au>Koh, Katsuyoshi</au><au>Hasegawa, Daiichiro</au><au>Saito, Akiko M.</au><au>Adachi, Souichi</au><au>Tomizawa, Daisuke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome</atitle><jtitle>Leukemia</jtitle><stitle>Leukemia</stitle><date>2021-12-01</date><risdate>2021</risdate><volume>35</volume><issue>12</issue><spage>3622</spage><epage>3624</epage><pages>3622-3624</pages><issn>0887-6924</issn><eissn>1476-5551</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><doi>10.1038/s41375-021-01397-w</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-5471-7646</orcidid><orcidid>https://orcid.org/0000-0002-9446-9568</orcidid><orcidid>https://orcid.org/0000-0002-0168-2475</orcidid><orcidid>https://orcid.org/0000-0002-1994-113X</orcidid><orcidid>https://orcid.org/0000-0003-1520-7007</orcidid><orcidid>https://orcid.org/0000-0002-0061-9781</orcidid><orcidid>https://orcid.org/0000-0001-8763-0280</orcidid><orcidid>https://orcid.org/0000-0003-3136-5670</orcidid><orcidid>https://orcid.org/0000-0002-3226-556X</orcidid><orcidid>https://orcid.org/0000-0002-7710-2449</orcidid><orcidid>https://orcid.org/0000-0003-0525-4766</orcidid><orcidid>https://orcid.org/0000-0002-7582-0201</orcidid><orcidid>https://orcid.org/0000-0002-0476-4978</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0887-6924 |
| ispartof | Leukemia, 2021-12, Vol.35 (12), p.3622-3624 |
| issn | 0887-6924 1476-5551 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2568597913 |
| source | Alma/SFX Local Collection |
| subjects | 631/67/1059/99 692/499 Cancer Research Correction Critical Care Medicine Hematology Intensive Internal Medicine Medicine Medicine & Public Health Oncology |
| title | Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A15%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to:%20Post-induction%20MRD%20by%20FCM%20and%20GATA1-PCR%20are%20significant%20prognostic%20factors%20for%20myeloid%20leukemia%20of%20Down%20syndrome&rft.jtitle=Leukemia&rft.au=Taga,%20Takashi&rft.date=2021-12-01&rft.volume=35&rft.issue=12&rft.spage=3622&rft.epage=3624&rft.pages=3622-3624&rft.issn=0887-6924&rft.eissn=1476-5551&rft_id=info:doi/10.1038/s41375-021-01397-w&rft_dat=%3Cgale_proqu%3EA684321652%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2604656430&rft_id=info:pmid/&rft_galeid=A684321652&rfr_iscdi=true |